Literature DB >> 31797408

Ontogeny of inter-alpha inhibitor protein (IAIP) expression in human brain.

Boram Kim1, Suzanne De La Monte2, Virginia Hovanesian3, Aparna Patra1, Xiaodi Chen1, Ray H Chen1, Miles C Miller4, Mehmet Halit Pinar5, Yow-Pin Lim5,6, Edward G Stopa4, Barbara S Stonestreet1.   

Abstract

Inter-alpha inhibitor proteins (IAIPs) are naturally occurring immunomodulatory molecules found in most tissues. We have reported ontogenic changes in the expression of IAIPs in brain during development in sheep and abundant expression of IAIPs in fetal and neonatal rodent brain in a variety of cellular types and brain regions. Although a few studies identified bikunin, light chain of IAIPs, in adult human brain, the presence of the complete endogenous IAIP protein complex has not been reported in human brain. In this study, we examined the immunohistochemical expression of endogenous IAIPs in human cerebral cortex from early in development through the neonatal period and in adults using well-preserved postmortem brains. We examined total, nuclear, and cytoplasmic staining of endogenous IAIPs and their expression in neurofilament light polypeptide-positive neurons and glial fibrillary acidic protein (GFAP)-positive astrocytes. IAIPs were ubiquitously detected for the first time in cerebral cortical cells at 24-26, 27-28, 29-36, and 37-40 weeks of gestation and in adults. Quantitative analyses revealed that IAIPs were predominately localized in the nucleus in all age groups, but cytoplasmic IAIP expression was more abundant in adult than in the younger ages. Immunoreactivity of IAIPs was expressed in neurons and astrocytes in all age groups. In addition, IAIP co-localization with GFAP-positive astrocytes was more abundant in adults than in the developing brain. We conclude that IAIPs exhibit ubiquitous expression, and co-localize with neurons and astrocytes in the developing and adult human brain suggesting a potential role for IAIPs in development and endogenous neuroprotection.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  astrocytes; brain development; human autopsy; immunohistochemistry; inter-alpha inhibitors; neurons

Mesh:

Substances:

Year:  2019        PMID: 31797408      PMCID: PMC7072009          DOI: 10.1002/jnr.24565

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  93 in total

1.  Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart.

Authors:  Z L Cao; Y Okazaki; K Naito; T Ueno; M Natsuaki; T Itoh
Journal:  Ann Thorac Surg       Date:  2000-04       Impact factor: 4.330

Review 2.  Neonatal brain injury.

Authors:  Donna M Ferriero
Journal:  N Engl J Med       Date:  2004-11-04       Impact factor: 91.245

3.  The diagnostic value of inter-alpha inhibitor proteins for neonatal sepsis.

Authors:  Pieter L J Degraeuwe; Fred H M Nieman
Journal:  J Pediatr       Date:  2010-02       Impact factor: 4.406

Review 4.  An Integrated Model of Slow-Wave Activity and Neuroplasticity Impairments in Major Depressive Disorder.

Authors:  Jennifer R Goldschmied; Philip Gehrman
Journal:  Curr Psychiatry Rep       Date:  2019-03-18       Impact factor: 5.285

5.  Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC.

Authors:  M L Hamshere; J T R Walters; R Smith; A L Richards; E Green; D Grozeva; I Jones; L Forty; L Jones; K Gordon-Smith; B Riley; F A O'Neill; T O'Neill; K S Kendler; P Sklar; S Purcell; J Kranz; D Morris; M Gill; P Holmans; N Craddock; A Corvin; M J Owen; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2012-05-22       Impact factor: 15.992

6.  Distribution of acid stable trypsin inhibitor immunoreactivity in normal and malignant human tissues.

Authors:  E Yoshida; H Sumi; M Maruyama; H Tsushima; Y Matsuoka; M Sugiki; H Mihara
Journal:  Cancer       Date:  1989-08-15       Impact factor: 6.860

7.  Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2.

Authors:  Tamra E Werbowetski-Ogilvie; Nathalie Y R Agar; Roberta M Waldkircher de Oliveira; Damien Faury; Jack P Antel; Nada Jabado; Rolando F Del Maestro
Journal:  Cancer Res       Date:  2006-02-01       Impact factor: 12.701

8.  Systemic differential gene regulation of the inter-α-trypsin inhibitor family in acute necrotizing pancreatitis in mice.

Authors:  Gabriel Seifert; Rolf-Pascal Kurzinger; Ulrich T Hopt; Uwe A Wittel
Journal:  J Surg Res       Date:  2012-04-17       Impact factor: 2.192

Review 9.  Inter-alpha-inhibitor, hyaluronan and inflammation.

Authors:  Erik Fries; Aneta Kaczmarczyk
Journal:  Acta Biochim Pol       Date:  2003       Impact factor: 2.149

10.  ITIH3 polymorphism may confer susceptibility to psychiatric disorders by altering the expression levels of GLT8D1.

Authors:  Daimei Sasayama; Hiroaki Hori; Noriko Yamamoto; Seiji Nakamura; Toshiya Teraishi; Masahiko Tatsumi; Kotaro Hattori; Miho Ota; Teruhiko Higuchi; Hiroshi Kunugi
Journal:  J Psychiatr Res       Date:  2013-12-15       Impact factor: 4.791

View more
  3 in total

Review 1.  The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.

Authors:  Megan S Lord; James Melrose; Anthony J Day; John M Whitelock
Journal:  J Histochem Cytochem       Date:  2020-07-08       Impact factor: 2.479

Review 2.  Novel Neuroprotective Agents to Treat Neonatal Hypoxic-Ischemic Encephalopathy: Inter-Alpha Inhibitor Proteins.

Authors:  Liam M Koehn; Xiaodi Chen; Aric F Logsdon; Yow-Pin Lim; Barbara S Stonestreet
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

3.  Urine inter-alpha-trypsin inhibitor family-related proteins may serve as biomarkers for disease activity of lupus.

Authors:  Jun Jiang; Jin Zhao; Yuhua Wang; Dan Liu; Man Zhang
Journal:  J Clin Lab Anal       Date:  2022-07-23       Impact factor: 3.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.